151 related articles for article (PubMed ID: 28454375)
1. A comprehensive analysis of cancer-driving mutations and genes in kidney cancer.
Long C; Jian J; Li X; Wang G; Wang J
Oncol Lett; 2017 Apr; 13(4):2151-2160. PubMed ID: 28454375
[TBL] [Abstract][Full Text] [Related]
2. An integrated analysis of cancer genes in thyroid cancer.
Chai L; Li J; Lv Z
Oncol Rep; 2016 Feb; 35(2):962-70. PubMed ID: 26718127
[TBL] [Abstract][Full Text] [Related]
3. Functional annotation of noncoding variants and prioritization of cancer-associated lncRNAs in lung cancer.
Li H; Lv X
Oncol Lett; 2016 Jul; 12(1):222-230. PubMed ID: 27347129
[TBL] [Abstract][Full Text] [Related]
4. Epigenomic annotation of noncoding mutations identifies mutated pathways in primary liver cancer.
Lowdon RF; Wang T
PLoS One; 2017; 12(3):e0174032. PubMed ID: 28333948
[TBL] [Abstract][Full Text] [Related]
5. Mutation pattern is an influential factor on functional mutation rates in cancer.
Du C; Wu X; Li J
Cancer Cell Int; 2015; 16():2. PubMed ID: 26865835
[TBL] [Abstract][Full Text] [Related]
6. Comparison of different functional prediction scores using a gene-based permutation model for identifying cancer driver genes.
Nono AD; Chen K; Liu X
BMC Med Genomics; 2019 Jan; 12(Suppl 1):22. PubMed ID: 30704472
[TBL] [Abstract][Full Text] [Related]
7. OncodriveCLUST: exploiting the positional clustering of somatic mutations to identify cancer genes.
Tamborero D; Gonzalez-Perez A; Lopez-Bigas N
Bioinformatics; 2013 Sep; 29(18):2238-44. PubMed ID: 23884480
[TBL] [Abstract][Full Text] [Related]
8. Profile of Basal Cell Carcinoma Mutations and Copy Number Alterations - Focus on Gene-Associated Noncoding Variants.
Nawrocka PM; Galka-Marciniak P; Urbanek-Trzeciak MO; M-Thirusenthilarasan I; Szostak N; Philips A; Susok L; Sand M; Kozlowski P
Front Oncol; 2021; 11():752579. PubMed ID: 34900699
[TBL] [Abstract][Full Text] [Related]
9. Functional impact bias reveals cancer drivers.
Gonzalez-Perez A; Lopez-Bigas N
Nucleic Acids Res; 2012 Nov; 40(21):e169. PubMed ID: 22904074
[TBL] [Abstract][Full Text] [Related]
10. LARVA: an integrative framework for large-scale analysis of recurrent variants in noncoding annotations.
Lochovsky L; Zhang J; Fu Y; Khurana E; Gerstein M
Nucleic Acids Res; 2015 Sep; 43(17):8123-34. PubMed ID: 26304545
[TBL] [Abstract][Full Text] [Related]
11. Prioritization of non-coding disease-causing variants and long non-coding RNAs in liver cancer.
Li H; He Z; Gu Y; Fang L; Lv X
Oncol Lett; 2016 Nov; 12(5):3987-3994. PubMed ID: 27895760
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive characterization of cancer genes in hepatocellular carcinoma genomes.
Zhang Z; Xu L; Sun C
Oncol Lett; 2018 Feb; 15(2):1503-1510. PubMed ID: 29434842
[TBL] [Abstract][Full Text] [Related]
13. IW-Scoring: an Integrative Weighted Scoring framework for annotating and prioritizing genetic variations in the noncoding genome.
Wang J; Dayem Ullah AZ; Chelala C
Nucleic Acids Res; 2018 May; 46(8):e47. PubMed ID: 29390075
[TBL] [Abstract][Full Text] [Related]
14. Revealing selection in cancer using the predicted functional impact of cancer mutations. Application to nomination of cancer drivers.
Reva B
BMC Genomics; 2013; 14 Suppl 3(Suppl 3):S8. PubMed ID: 23819556
[TBL] [Abstract][Full Text] [Related]
15. Annotation of Variant Data from High-Throughput DNA Sequencing from Tumor Specimens: Filtering Strategies to Identify Driver Mutations.
Sun S; Thorson JA; Murray SS
Methods Mol Biol; 2019; 1908():49-60. PubMed ID: 30649720
[TBL] [Abstract][Full Text] [Related]
16. Identification of recurrent noncoding mutations in B-cell lymphoma using capture Hi-C.
Cornish AJ; Hoang PH; Dobbins SE; Law PJ; Chubb D; Orlando G; Houlston RS
Blood Adv; 2019 Jan; 3(1):21-32. PubMed ID: 30606723
[TBL] [Abstract][Full Text] [Related]
17. Next-generation sequencing for molecular diagnosis of autosomal recessive polycystic kidney disease.
Edrees BM; Athar M; Al-Allaf FA; Taher MM; Khan W; Bouazzaoui A; Al-Harbi N; Safar R; Al-Edressi H; Alansary K; Anazi A; Altayeb N; Ahmed MA; Abduljaleel Z
Gene; 2016 Oct; 591(1):214-226. PubMed ID: 27401137
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the von Hippel-Lindau (VHL) gene refine differential diagnostic criteria in renal cell carcinoma.
Barnabas N; Amin MB; Pindolia K; Nanavati R; Amin MB; Worsham MJ
J Surg Oncol; 2002 May; 80(1):52-60. PubMed ID: 11967908
[TBL] [Abstract][Full Text] [Related]
19. Pan-cancer screen for mutations in non-coding elements with conservation and cancer specificity reveals correlations with expression and survival.
Hornshøj H; Nielsen MM; Sinnott-Armstrong NA; Świtnicki MP; Juul M; Madsen T; Sallari R; Kellis M; Ørntoft T; Hobolth A; Pedersen JS
NPJ Genom Med; 2018; 3():1. PubMed ID: 29354286
[TBL] [Abstract][Full Text] [Related]
20. Integrative analysis of cancer driver genes in prostate adenocarcinoma.
Zhao X; Lei Y; Li G; Cheng Y; Yang H; Xie L; Long H; Jiang R
Mol Med Rep; 2019 Apr; 19(4):2707-2715. PubMed ID: 30720096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
